Next-Generation Therapies and Technologies for Immune-Mediated Inflammatory Diseases

As our understanding of immune mediated chronic inflammatory diseases (IMIDs) grows, it becomes more and more clear that these conditions result from the convergence of a multitude of pathogenic mechanisms whose relative individual contribution is different in different patient subsets. Promising ne...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: Mina-Osorio, Paola (Επιμελητής έκδοσης)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Cham : Springer International Publishing : Imprint: Springer, 2017.
Σειρά:Progress in Inflammation Research
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
Πίνακας περιεχομένων:
  • Preface
  • Targeted drug delivery
  • I. Bispecific antibodies
  • II. Targeting neovessels with NGR peptides
  • Genomic-based drugs
  • III. Micro-RNA/aptamers
  • Nanomedicine
  • IV. Exosomes
  • V. Microparticles
  • Cross-functional targets
  • VI. Metabolic targets in inflammation
  • VII. Targeting gut microbiome-immune system interactions
  • VIII. Targeting the nervous system as an add on therapy for autoinflammatory conditions
  • Biomarkers
  • IX. Biomarkers in drug discovery
  • Other therapies
  • X. Stem cell therapy in the treatment of rheumatic disease and application in the treatment of systemic lupus erythematosus.